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ABSTRACT
Brown adipose tissue is a special type of fat contributing to energy expenditure in human newborns and adults. Moreover, 
subcutaneous white adipose tissue has a high capacity to adapt an energy-consuming, brown-like/beige phenotype. 
Here, we developed an easy to handle and fast to accomplish method to efficiently transfer genes into brown and beige 
fat pads in vivo. Lentiviral vectors are directly injected into the target fat pad of anesthetized mice through a small inci-
sion using a modified, small needle connected to a microsyringe, which is well suited for infiltration of adipose tissues. 
Expression of the target gene can be detected in brown/beige fat one week after injection. The method can be applied 
within minutes to efficiently deliver transgenes into subcutaneous adipose tissues. Thus, this protocol allows for studying 
genes of interest in a timely manner in murine brown/beige fat and could potentially lead to new gene therapies for obesity.
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BACKGROUND
There is a high medical need to develop new strategies to treat 
overweight and obesity as these conditions have reached pandemic 
dimensions. Obesity and its comorbidities, such as type 2 diabetes, 
cardiovascular disease and certain kinds of cancer, are a major threat 
to global health  [1,2]. Brown adipocytes are promising targets as they 
consume energy and could be used to increase energy expenditure and 
facilitate weight loss and thereby counteract obesity.
Brown adipocytes are rich in mitochondria and express specifically 
the uncoupling protein 1 (UCP1). UCP1 is activated by free fatty acids 
and uncouples the proton gradient within the mitochondria leading to 
generation of heat instead of ATP. Cold exposure leads to sympathet-
ic activation of lipolysis and consequent activation of UCP1 by the 
released free fatty acids [3]. Newborn humans and small mammals 
possess brown adipose tissue (BAT) that produces heat to maintain 
body temperature [4]. Importantly, metabolically active BAT can also 
be found in human adults [5,6,7] and activation and/or recruitment of 
human BAT can increase whole body metabolism [8,9].
Apart from interscapular BAT, inducible brown adipocytes, so called 
beige or brite (brown-in-white) cells, have been found disseminated in 
white adipose tissue (WAT). Beige cells also contain a high number of 
UCP1-expressing mitochondria and consume energy similar to “clas-
sical” brown adipocytes [10]. The number of beige adipocytes can be 
increased by different stimuli like cold exposure or by certain drugs 
[11]. Among WAT depots the subcutaneous, inguinal WAT (WATi) has 
a high susceptibility to browning in mice and men [12,13,14]. Even 
though the knowledge about brown and beige adipocytes has increased 
significantly during the last years there are still many open questions.
Lentiviruses are enveloped, single stranded RNA viruses that belong to 
the family of Retroviridae. An important difference between lentiviruses 
and simple retroviruses is that lentiviruses have the unique ability to 
infect non-dividing, terminally differentiated eukaryotic cells. There-
fore, they are widely used as an efficient method for gene transfer [15].
Here we describe a protocol of direct lentivirus injection into subcu-
taneous brown and beige adipose depots for efficient gene transfer into 
brown/beige adipocytes. The role of target genes can thereby be studied 
in brown and beige fat in vivo as well as in whole body metabolism 
without the need to establish transgenic mouse lines. Furthermore, this 
method could also serve as a potential gene therapy approach which 
specifically targets subcutaneous beige or brown fat depots.
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Development of the protocol
Lentiviruses efficiently transfer genes into white and brown adipo-
cytes in vitro [16,17] and have been shown to transduce WAT [18,19]. 
We have developed and optimized the protocol for lentivirus injection 
into BAT and to induce beige cells in WATi. Importantly, the custom 
adapted injection device allows for the injection of small volumes 
through a very small needle to avoid significant tissue damage. The set-
up provides clear visual control during injection without contamination 
of the glass syringe by virus.
Experimental design
The use of lentivirus allows employing a large variety of constructs. 
Lentivirus can either be used to overexpress genes or to knockdown genes 
using shRNA or miRNA [20]. For every experiment it is important to use 
respective controls. The buffers used for dissolving the viral particles, 
e.g., phosphate buffered saline (PBS) or Hank’s balanced salt solution 
(HBSS), can be used for mock injections. Moreover, either “empty” 
viruses without transgene cassette or viral vectors carrying a reporter 
gene like green fluorescent protein (GFP) can be injected as controls. 
Especially for shRNAs or miRNAs a scrambled control vector should 
be used. It is possible to have intra-individual, internal controls within 
one mouse by injecting the gene of interest into only one fat lobe and 
the respective control into the other. This is useful if overexpression 
or knockdown efficiency within one mouse is investigated but should 
not be applied if whole body metabolism is studied.
Mice that have been injected with lentivirus can be included into long 
term studies, because the lentivector integrates into the host genome. 
Expression of the transgene is stable for at least 6 weeks [19].
Comparison with other methods
Until now, fat tissue specific overexpression or knockdown of target 
genes was mostly accomplished by generating specific transgenic or 
knockout mouse models by subzonal injections of lentivirus into fertilized 
oocytes or using the Cre-lox recombination system, respectively [21]. 
Even though these methods are proficient in transferring or deleting 
the gene of interest into specific tissues by tissue-specific promoters, 
they are also very time consuming and expensive. Furthermore, a large 
number of mice are needed for breeding to establish a specific mouse line.
Direct lentiviral injection into brown/beige fat, does not involve 
breeding or genotyping of mouse lines and hence dramatically reduces the 
time required to express a gene of interest in fat pads as well as number 
of animals and costs. Another advantage of the method described here is 
the gene transfer into specific fat pads (e.g.,  only WATi, but not BAT). 
So far this cannot be accomplished with transgenesis as there are no 
promoters available which specifically target only one of these fat pads, 
e.g.,  the UCP1 promoter is active in both brown and beige cells [22].
The described set-up/method can also be used to deliver genes of 
interest into existing transgenic animals as well as for delivery of other 
viral vectors [23], like vectors derived from adenovirus or adeno-as-
sociated virus (AAV). AAV-derived particles are considered biohazard 
level 1; however, a major disadvantage is the small packaging capacity 
of classical AAV vectors [24,25]. An important feature of lentiviral 
vectors is their integration into the host genome ensuring long-term 
expression. Moreover, one-and-the-same vector can be used to generate 
transgenic animals by subzonal injection (lentiviral transgenesis) [20].
Using the method described here, it is possible to generate genetically 
modified mice within minutes.
Limitations
We recommend using mice of at least 4 weeks of age for injections 
into BAT and WATi. The presented method is primarily designed for 
subcutaneous fat tissues, which are easily accessible via a small skin 
incision. In principal, injections into visceral fat are possible, but injection 
into the epididymal adipose tissue would require opening the abdominal 
cavity. In the adipose tissue, not only adipocytes will be transduced 
with this method but all present cells (e.g., preadipocytes, fibroblasts, 
immune cells, endothelial cells). Adipocyte-specific expression can 
be achieved with specific promoters to control expression of the target 
gene, e.g.,  the fatty acid-binding protein 4 (aP2) promoter for all fat 
cells or the UCP1 promoter for only brown and beige fat cells [22]. To 
achieve cell-specific transduction, one could design viruses that have 
an adipocyte-specific fusogen that delivers the virus to designated cell 
types only [26]. ASC-1, PAT2, and P2RX5 could serve as specific surface 
markers for white, beige and brown adipocytes [27].
MATERIALS
General considerations on safety issues
All experiments have to be performed in accordance to relevant 
guidelines and protocols and have to be approved by local authorities 
including ethics/animal health committees. The study described herein 
has been approved by the Landesamt für Natur, Umwelt und Verbrauch-
erschutz, NRW, Germany. Working with lentiviruses is restricted to 
biosafety level 2 (BSL-2) facilities. Appropriate personal protection 
equipment such as gloves and lab coat are required when working 
with these vectors. The paper “State-of-the-Art Lentiviral Vectors for 
Research Use: Risk Assessment and Biosafety Recommendations” by 
Katia Pauwels et al. (2009) [28] provides a good overview about risk 
assessment and biosafety recommendations when working with lenti-
viral vectors. Mice injected with replication-deficient virus are usually 
classified as BSL-1 organisms and can therefore be handled as any other 
BSL-1 laboratory mouse. However, as legislation might differ between 
countries, it is essential to review the local guidelines and precautions 
for handling viruses in BSL-2 facilities as well as lentiviral-injected 
mice before starting with the procedure.
Animals
We have successfully overexpressed transgenes with direct lentivirus 
injection into brown (interscapular BAT) and beige (WATi) adipose 
tissue in C57Bl/6 mice at 4 weeks of age or older. Other mouse strains 
might be as suitable for the method as C57Bl/6 mice, but adjustment of 
the protocol might be necessary. For example when using ob/ob mice, 
it is necessary to adjust the number of viral particles depending on the 
increase in adipose tissue mass compared to wild-type controls. We 
recommend testing the procedure with Trypan blue solution or with a 
reporter construct (e.g., GFP) before starting with the actual experiments.
Reagents
 9 Ethanol 70%
 9 Isoflurane (Abbott), 1–2.5% (w/v) in oxygen. CAUTION: 
Isoflurane is harmful if inhaled, swallowed or upon skin con-
tact. Wear appropriate personal protection equipment and use 
devices with carbon filters to minimize exposure to isoflurane.
 9 Trypan blue solution, 0.4%, CAUTION: Trypan blue might be 
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hazardous to your health, wear appropriate personal protection 
equipment such as gloves when working with trypan blue.
 9 Packaging plasmids pMDLg/pRRE, RSV-rev and pMD.G for 
lentivirus production
 9 High titer lentivirus encoding the desired gene or reporter. The 
virus is produced according to established protocols [21]. The 
lentiviral vector was obtained by cloning GFP into the Bam 
HI and Sal I sites of the vector p156rrlsinPPT, which carries a 
ubiquitous CMV promoter. CAUTION: Adhere to biosafety 
regulations and only use the virus within a BSL-2 facilities. 
The virus can only be handled within a safety cabinet. Wear 
appropriate personal protection equipment such as gloves 
and lab coat.
 9 HBSS (Hank’s Balanced Salt Solution, Life technologies)
 9 Carprofen (Rimadyl, Pfizer)
Reagent setup
Virus solution. High titer lentivirus should be prepared according 
to established protocols [21,29]. In short, HEK 293T cells (ATCC) are 
seeded on poly-L-lysine-coated 150-mm2 dishes and co-transfected with 
the lentiviral vector plasmid as well as the packaging plasmids pMDLg/
pRRE, RSV-rev and pMD.G. After transfection, cells are incubated at 
37°C and 3% CO2 overnight. The transfection medium is then exchanged 
and cells are further incubated at 37°C and 10% CO2. The secreted virus 
is harvested after another 24 h and 48 h by collecting the supernatant of 
the cells. This supernatant is centrifuged by an ultracentrifuge (Beck-
man Coulter) with SW32Ti rotor at 61,700 g at 17°C for 2 h to pellet 
the secreted virus. The virus pellet is resuspended in HBSS. Combined 
virus suspensions after 24 h and 48 h are concentrated by centrifuga-
tion over a 20% (w/v) sucrose cushion in a SW55Ti rotor (Beckman 
Coulter) at 53,500 g at 17°C for 1.5 h and again solved in HBSS. The 
physical titer of the lentivirus can be assessed by colorimetric reverse 
transcriptase (RT) assay (Roche). Dilute lentivirus in HBSS, to achieve 
desired volume for injection (i.e. 20–30 µl for each fat lobe). In this 
protocol 1000 ng/25 µl (BAT) and 1000 ng/30 µl (WATi) of lentivirus 
were injected into each fat lobe.
Equipment
 9 Surgical swabs (Paul Hartmann)
 9 Animal hair clipper (AESCULAP GT420)
 9 Isoflurane anesthesia system (Vapor, Dräger)
 9 Nanopass33 (33G needle for pen injectors, Terumo Corp.)
 9 Fine-Bore Polyethylene (Polythene) Tubing (ID 0.28 mm, OD 
0.61 mm, Smiths Medical)
 9 Microsyringe (Hamilton)
 9 Tungsten carbide scissors (Fine Science Tools)
 9 Surgical scissors (Fine Science Tools)
 9 Curved forceps (Fine Science Tools)
 9 Straight forceps (Fine Science Tools)
 9 Michel suture clips (Fine Science Tools)
 9 Michel clip applicator (Fine Science Tools)
 9 Heating pad
Equipment setup
Injection device. Cut off outer plastic rim around the pen-needle (Fig. 
1A) and connect it to the polyethylene (PE) tubing (20–30 cm in length). 
Be careful not to puncture the tubing with the pen needle which is sharp 
at both sides. Connect a Hamilton microsyringe to the other side of the 
tubing (Fig. 1B). To test whether all connections are tight and correctly 
sealed, flush the injection device with PBS. The virus solution can now 
be drawn up with the microsyringe into the plastic tubing and will be 
visible within the tubing. The injection device is now ready to use.
CAUTION: Adhere to biosafety regulations in terms of 
handling and disposal of virus and virus containing material.
PROCEDURE
In vitro testing of lentiviral vectors
We recommend testing your lentiviral construct in vitro before injecting it into mice. Such a test could be performed 
as follows:
1. Seed preadipocytes and let attach.
2. Transduce with different amounts of virus (e.g.,  50 ng and 200 ng per 6-well).
3. Differentiate the cells according to standard differentiation protocol [19,30].
4. Expression of the transgene can be quantified using qRT-PCR for mRNA expression, Western blotting for 
protein expression (Fig. S1A-S1B) or microscopic analysis at different time points during differentiation if 
using a reporter gene (Fig. S1C-S1D).
In vivo injection of lentiviral vectors
5. Inject mice with analgesic (Carprofen 5 mg/kg body weight) 30 min before starting the procedure.
6. Under the safety cabinet draw up the desired amount of virus. We recommend using a volume of 20–30 µl 
in each fat lobe of BAT and WATi.
7. Anaesthetize mice with isoflurane: Anesthesia is induced with 2.5% (w/v) isoflurane and maintained with 1% 
(w/v) isoflurane in O2. CAUTION: Test if anesthesia is deep enough by pinching the skin between the toes. 
No withdrawal should be observed.
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8. Shave the small area in the interscapular region for injections into BAT (Fig. 1C) and at the flanks, proxi-
mal of hip joints for injections into WATi/beige fat with hair clipper (Fig. 1D). Clean the skin with ethanol.
9. Make a 0.5–0.8 cm incision in the skin using surgical scissors (see red lines in Fig. 1C and 1D).
10. Hold skin open with tweezers to expose fat pad. Visualize BAT with surrounding/adjacent white fat pads 
(Fig. 1E) or the dorsal tip of the WATi pad (Fig. 1F). For injections into WATi use tweezers to shift the fat 
pad upwards through the incision and expose the pad without completely removing it from its native position.
11. Take the injection device and carefully insert the pen needle into the fat pad. Only when the needle is inserted 
deep enough start to inject lentiviral vectors into multiple (5–10) distinct spots in the fat pad using the fine 
needle (total 20–30 µl per lobe).
12. After the virus solution is injected completely, carefully take out the needle and dispose the needle together 
with the tubing according to local regulations.
13. Close the incision with Michel suture clips.
14. Post surgery, monitor health status of the mice daily and treat the mice with analgesic (Carprofen 5 mg/kg 
body weight) for two days or longer if you have hints that the mouse is still in pain (not normal behavior, 
e.g.,  less exploring and rearing; outer appearance, e.g.,  shaggy fur, blurry eyes, inflammation of the wound). 
Recovery from the small surgery is usually very quick and the suture clips can be removed or are lost generally 
after 7–14 days. CAUTION: always refer to approval by local ethics/animal health committees.
15. Analysis: The injected mice can be retained for any desired time period from days up to several weeks and 
can even be used for further in vivo experiments after the appropriate recovery time (e.g., metabolic mea-
surements, special dietaries, glucose tolerance tests).
Timing
Steps 5-6, preparation and pre-treatment of mice: 30 min
Steps 7-13: 10-15 min
Step 14: 2 days or longer
Step 15: Any desired time point
Figure 1. Set up of injection device and establishment of protocol. A. Original pen needle (dashed line indicates the cutting area) (left) and needle 
after cutting off plastic rim (right). Scale bar = 0.5 cm. B. Illustration showing setup of injection device. C and D. Pictures of anesthetized and shaved 
mouse, incision sites are marked by a red line in the interscapular region (C) or at the flanks, proximal of hips (D). E. Situs after injection of 10 μl and 
20 μl Trypan blue solution in BAT. F. Situs after injection of 10 μl and 20 μl Trypan blue solution in the upper region of WATi. G. Dissected BAT from (E). 
H. Dissected WATi from (F).
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Figure 2. GFP fluorescence in interscapular BAT after lentivirus injection.  A-C. 1000 ng RT of lentivirus carrying GFP under control of a CMV pro-
moter (GFP) in 25 μl HBSS or 25 μl PBS were injected into each interscapular BAT lobe of 4-week-old male mice and analyzed after 1 week. A. Bright field 
(BF, left) and fluorescent images (FL, right) of PBS (upper panel) and GFP (lower panel) injected BAT. B. GFP expression assessed by Western blotting. 
Respective blots of GFP and the loading control GAPDH are shown. C. GFP expression assessed by immunohistological staining. PFA-fixed BAT sections 
were triple stained with antibodies directed against GFP (green) and Perilipin (red) as well as with ToPro3 (blue) to stain the nuclei. Scale bar = 50 µm.
ANTICIPATED RESULTS
In vitro testing of lentiviral vectors
To test that your lentiviral vector is working in principle, it is rec-
ommended to test it in vitro before injecting it into your mice. We 
transduced brown (BA) and inguinal white adipocytes (WAi) with two 
different amounts of lentivirus carrying GFP under the control of a 
cytomegalovirus (CMV) promoter (i.e., 50 ng and 200 ng per 150,000 
seeded cells) and differentiated the cells to mature adipocytes according 
to standard protocol. Proteins from terminally differentiated cells were 
isolated and Western blotting was performed to analyze GFP expression, 
which was only present in transduced BA and WAi but not in untrans-
duced control (ctrl) cells (Fig. S1A-S1B). During differentiation GFP 
expression was confirmed by means of fluorescent microscopy, showing 
expression of GFP in preadipocytes (d-2) as well as in mature BA and 
WAi (d7) (Fig. S1C-S1D).
Establishment of protocol using Trypan blue solution
Before injecting precious lentivirus solutions, we recommend to get 
used to the protocol with the use of Trypan blue solution. After following 
the protocol as outlined in the PROCEDURE section the adipose tissue 
pads should appear in a blue color as shown in Figure 1E-1H.
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GFP expression in BAT and WATi
One week after injection of 1000 ng lentivirus carrying GFP under 
the control of a cytomegalovirus (CMV) promoter per BAT lobe, flu-
orescence was clearly visible in the dissected fat pads (Fig. 2A). The 
results were validated using Western blotting (Fig. 2B), which showed 
expression of GFP in lentivirus-injected mice but not in mice injected 
with PBS. Furthermore, we performed immunofluorescent staining of 
GFP, Perilipin (adipocyte marker) and ToPro3 (nucleus staining) in 
PFA-fixed sections of lentivirus-injected BAT pads to analyze brown 
adipocyte specific GFP expression (Fig. 2C). Similar results were 
obtained after injection of WATi (Fig. 3A-3C). Even though the same 
amount of lentivirus (i.e., 1000 ng/fat lobe) was injected into BAT and 
WATi, expression levels of GFP were significantly lower in WATi in 
comparison to BAT (Fig. 4A). This is probably due to the larger overall 
size of WATi, which reduces the number of viral particles per gram of 
tissue. We recommend using a higher amount of lentivirus for injections 
into WATi than into BAT. Sirius Red staining of lentivirus-injected BAT 
pads detected no damage in the injected tissue due to the small injection 
needle used (Fig. 4B).
In conclusion, we present a fast and easy applicable method to ef-
ficiently transfer genes into murine brown and beige adipocytes using 
lentiviral vectors.
Figure 3. Expression of GFP in inguinal WAT (WATi) after lentivirus injection. A-C. 1000 ng RT of lentivirus carrying GFP under control of a CMV 
promoter (GFP) in 30 μl HBSS or 30 μl PBS were injected into each WATi pad of 10-week-old male mice and analyzed after 1 week. A. Bright field (BF, 
left) and fluorescent images (FL, right) of PBS (upper panel) and GFP (lower panel) injected WATi. B. GFP expression assessed by Western blotting. 
Respective blots of GFP and the loading control GAPDH are shown. C. GFP expression assessed by immunohistological staining. PFA-fixed WATi sections 
were triple stained with antibodies directed against GFP (green) and Perilipin (red) as well as with ToPro3 (blue) to stain the nuclei. Scale bar = 50 µm.
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Figure 4. Comparison of GFP expression in BAT and WATi and Sirius Red staining of BAT. A. GFP expression in BAT and WATi after injection of 1000 
ng RT of lentivirus carrying GFP into each fat lobe assessed by Western blotting (top) and quantitative analysis (bottom). *P < 0.05 (n = 3). B. Representa-
tive BAT sections of PBS- and GFP-injected mice, stained with Sirius Red for collagen (I and III) fibres. Scale bar top = 1 mm; scale bar bottom = 100 µm.
TROUBLESHOOTING Potential problems and their causes and solutions are listed in Table 1.
Table 1. Troubleshooting.
Step Problems Causes Suggestions
6 Impossible to 
draw up virus
• Virus solution is too viscous • Dilute in larger volume of virus solvent
• PE tubing is damaged • Use a new piece of tubing and be very careful when connecting it to the 
pen needle
• Pen needle is damaged or 
clogged
• Use a new pen needle
7 Anaesthesia does 
not work
• Isoflurane dose is too low • Carefully increase dose of isoflurane until mouse loses consciousness 
and does not react to pinch test anymore. Check mouse constantly for 
signs of awakening.
• Isoflurane anesthesia system is 
not set up properly
• Check all connections
14 Incision becomes 
inflamed
• Surgical instruments were not 
properly cleaned
• Sterilize and autoclave all used surgical instruments properly
• Hair was not properly removed 
and entered the wound
• Remove fur in a larger area around the incision. Use ethanol to clean 
sticking hair
• Transferred gene induces inflam-
mation
15 No or too low 
expression of 
transferred gene
• Fat pads were not injected 
properly
• Practice the method using Trypan blue solution (see Fig. 1E-1H) to 
make sure the correct spots are injected. Be careful not to put the nee-
dle too deep or too shallow. Try to inject in as many different spots as 
possible to ensure expression in the whole tissue.
• Low expression efficiency of 
lentiviral vector
• Test efficiency of lentiviral vector in vitro, if possible try to increase 
amount of injected lentivirus
• Analysis is done too early • We recommend waiting at least 48–72 h post injection before starting 
with analysis to ensure proper transduction of the tissues and expres-
sion of the transferred gene.
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